Skip to content

Phreesia PHR Free cash flow

Free cash flow at other companies

Claritev Corporation logo
Claritev CorporationCTEV
-$92.55M-34.3%
Corvel logo
CorvelCRVL
$20.29M+42.3%
ExlService Holdings logo
ExlService HoldingsEXLS
-$11.21M-15.6%
Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
-$21.16M-27.6%
iRadimed logo
iRadimedIRMD
$7.89M+1,226%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG

Other financials

Income statement

See full
Revenue$130.9M+12.9%
Gross profit$113.3M+14.1%
Operating income$6.7M+305%
Net income$3.0M+176%
EPS (diluted)$0.05+171%

Balance sheet

See full
Cash & equivalents$73.8M-12.3%
Total debt$98.3M+242%
Total equity$359.1M+27.3%
Total assets$666.1M+66.4%

Cash flow

See full
Operating cash flow$23.9M+61.1%
CapEx$4.3M+23.0%

Valuation

See full
Market cap$564.34M-63.8%
P/E61.5×
P/S1.1×-2.5×

Profitability

See full
Gross margin85.4%+0.8pp
Operating margin0.7%+0.4pp
Net margin1.9%+1.0pp
FCF margin15.3%+6.9pp

Returns & leverage

See full
Return on equity2.9%+1.5pp
Debt / equity0.3×+0.2×
Current ratio1.8×-0.2×

Where this comes from

Calculated from Phreesia’s reported figures.

The official record: Phreesia’s 10-Q, filed May 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Phreesia's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Phreesia's free cash flow?
Phreesia (PHR) reported free cash flow of $19.61M in Q1 2026.
How has Phreesia's free cash flow changed year-over-year?
Phreesia's free cash flow increased by 72.9% year-over-year, from $11.35M to $19.61M.
What is the long-term trend for Phreesia's free cash flow?
Over 4 years (2022 to 2026), Phreesia's free cash flow has grown at a -7.7% compound annual growth rate (CAGR), from -$93.13M to $67.71M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.